Cheol Ho Park

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Chronic Kidney Disease

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cell death discovery

Hypertension (Dallas, Tex. : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Cheol Ho Park, Hyung Woo Kim, Jung Tak Park, Tae Ik Chang, Tae-Hyun Yoo, Sue Kyung Park, Yaeni Kim, Ji Yong Jung, Jong Cheol Jeong, Kook-Hwan Oh, Shin-Wook Kang, Seung-Hyeok Han, null null
The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKD. Journal of internal medicine (2023)
Cheol Ho Park, Hyung Woo Kim, Jung Tak Park, Tae Ik Chang, Tae-Hyun Yoo, Joongyub Lee, Su Ah Sung, Ji Yong Jung, Young Youl Hyun, Kook-Hwan Oh, Shin-Wook Kang, Seung-Hyeok Han, null null
Intrarenal Renin-Angiotensin System Activation Alters Relationship Between Systolic Blood Pressure and Progression of Chronic Kidney Disease. Hypertension (Dallas, Tex. : 1979) 80 (5) (2023)
Cheol Ho Park, Tae-Hyun Yoo
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Cheol Ho Park, Tae-Hyun Yoo
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Cheol Ho Park, Bin Lee, Myeonggil Han, Woo Joong Rhee, Man Sup Kwak, Tae-Hyun Yoo, Jeon-Soo Shin
Canagliflozin protects against cisplatin-induced acute kidney injury by AMPK-mediated autophagy in renal proximal tubular cells. Cell death discovery 8 (1) (2022)
Cheol Ho Park, Tae-Hyun Yoo
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Cheol Ho Park, Hyung Woo Kim, Young Su Joo, Jung Tak Park, Tae Ik Chang, Tae-Hyun Yoo, Sue-Kyung Park, Dong-Wan Chae, Wookyung Chung, Yong Soo Kim, Kook-Hwan Oh, Shin-Wook Kang, Seung-Hyeok Han, null null
Association Between Systolic Blood Pressure Variability and Major Adverse Cardiovascular Events in Korean Patients With Chronic Kidney Disease: Findings From KNOW-CKD. Journal of the American Heart Association 11 (11) (2022)
Cheol Ho Park, Tae-Hyun Yoo
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Cheol Ho Park, Hyun Sook Lee, Man Sup Kwak, Jeon-Soo Shin
Inflammasome-Dependent Peroxiredoxin 2 Secretion Induces the Classical Complement Pathway Activation. Immune network 21 (5) (2021)